Radar reflector guided axillary surgery in node positive breast cancer patients

References

• Fisher CS, Margenthaler JA, Hunt KK, et al. The landmark series: axillary management in breast cancer. Ann Surg Oncol. 2020;27(3):724–729.
   PubMed Web of Science ®Google Scholar
• Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–575.
   PubMed Web of Science ®Google Scholar
• Mamounas EP, Brown A, Anderson S, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: results from national surgical breast and bowel project protocol B-27. J Clin Oncol. 2005;23:2694–2702.
   PubMed Web of Science ®Google Scholar
• Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicenter cohort study. Lancet Oncol. 2013;14:609–618.
   PubMed Web of Science ®Google Scholar
• Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2014;33:258–264.
   PubMedGoogle Scholar
• Classe JM, Loaec C, Gimbergues P, et al. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Breast Cancer Res Treat. 2019;73(2):343–352.
   Google Scholar
• Boughey JC, Ballman KV, Le-Petross HT, et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance). Ann Surg. 2016;263(4):802–807.
   PubMed Web of Science ®Google Scholar
• Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of a targeted axillary dissection. J Clin Oncol. 2016;34(10):1072–1078.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. Bone Cancer (Version 2.2021). Cited 2021 Mar 22. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
   Google Scholar
• Laws A, Dillon K, Kelly BN, et al. Node-Positive patients treated with neoadjuvant chemotherapy can be spared axillary lymph node dissection with wireless non-radioactive localizers. Ann Surg Oncol. 2020;27(12):4819–4827.
   PubMed Web of Science ®Google Scholar
• Wazir, Wazir U, Kasem I, et al. reflector- guided localisation of non-palpable breast lesions: a prospective evaluation of the SAVI SCOUT® system. Cancers (Basel). 2021;13(10):2409.
   PubMed Web of Science ®Google Scholar
• Cox CE, Garcia-Henriquez N, Glancy MJ, et al. Pilot study of a new nonradioactive surgical guidance technology for locating nonpalpable breast lesions. Ann Surg Oncol. 2016;23(6):1824–1830.
   PubMed Web of Science ®Google Scholar
• Cox CE, Russell S, Prowler V, et al. A prospective, single arm, multi-site, clinical evaluation of a nonradioactive surgical guidance technology for the location of nonpalpable breast lesions during excision. Ann Surg Oncol. 2016;23(10):3168–3174.
   PubMed Web of Science ®Google Scholar
• Mango V, Ha R, Gomberawalla A, et al. Evaluation of the SAVI SCOUT surgical guidance system for localization and excision of nonpalpable breast lesions: a feasibility study. AJR Am J Roentgenol. 2016;207(4):W69–72.
   PubMed Web of Science ®Google Scholar
• Mango VL, Wynn RT, Feldman S, et al. Beyond wires and seeds: reflector-guided breast lesion localization and excision. Radiology. 2016;284(2):365–371.
   Web of Science ®Google Scholar
• Cianna Medical. SCOUT radar localization for breast cancer surgery. Cited 2021 Mar 19. https://www.ciannamedical.com/savi-scout/.
   Google Scholar
• Taback B, Jadeja P, Ha R, et al. Enhanced axillary evaluation using reflector-guided sentinel lymph node biopsy: a prospective feasibility study and comparison with conventional lymphatic mapping techniques. Clin Breast Cancer. 2018;18(5):e869–74.
   PubMed Web of Science ®Google Scholar
• Sun J, Henry, D. A., Carr, M. J., Yazdankhahkenary, A., Laronga, C., Lee, M. C., & Kiluk, J. V. Feasibility of axillary lymph node localization and excision using radar reflector localization. Clin Breast Cancer. 2020 Aug;6:S1526–8209.
   Google Scholar
• Falcon S, Weinfurtner RJ, Mooney B, et al. Savi scout(r) localization of breast lesions as a practical alternative to wires: outcomes and suggestions for trouble-shooting. Clin Imaging. 2018;52:280–286.
   PubMed Web of Science ®Google Scholar
• Donker M, Straver ME, Wesseling J. Donker M et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Annals Surg. 2015 Feb;261(2):378–382.
   PubMed Web of Science ®Google Scholar
• Mittendorf E, King, T. A., & Tolaney, S. M. Impact of RxPONDER and monarchE on the surgical management of the axilla in patients with breast cancer. J Clin Oncol. 2022 Jun 8;40(29):JCO2200173.
   Web of Science ®Google Scholar
• Henke G, Knauer M, Ribi K, et al. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial. Trials. 2018 Dec 4;19(1):667.
   PubMedGoogle Scholar
• US Food and Drug Administration. FDA K181007 [Internet]. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf18/K181007.pdf
   Google Scholar
• Hayes. SAVI SCOUT improves breast surgery operating room start times compared with wire localization. Presentation at American Society of Breast Surgeons 18th Annual Meeting. April 2017, Dallas, TX.
   Google Scholar